TCF7L2 is one of the strongest GWAS hits for type 2 diabetes risk, but its relevance for sport performance is minimal. The gene influences insulin secretion and glucose metabolism, which could theoretically affect energy availability during endurance exercise. However, the effect size is small, and no direct evidence links TCF7L2 variants to athletic performance, recovery, or injury risk. Current knowledge is limited to diabetes predisposition, not sport-specific outcomes. Therefore, TCF7L2 is not useful for sport-related decisions. Athletes should focus on established modulators of metabolic health (nutrition, training load, sleep) rather than single-gene variants. Caveat: No validated genotype-based intervention exists for sport; avoid overinterpretation of consumer genetic reports.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-f4184caa0ac22cee3dc19420